心血管参与ANCA相关的血管炎
Ahmad Sarmad1, Zohreh Gholizadeh Ghozloujeh2, Paul E Hanna3
1Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
概括
患有抗中性粒细胞质抗体 (ANCA) 相关血管炎 (AAV) 的患者心血管事件的风险显著增加. 这篇评论探讨了AAV的AAV.
科学领域:
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
背景情况:
- 抗中性细胞质抗体 (ANCA) 相关的血管炎 (AAV) 是一种全身性丧尸性血管炎,具有重大心血管影响.
- AAV患者患心血管事件的风险增加65%,包括心肌梗塞和中风.
研究的目的:
- 审查目前有关心血管参与AAV的文献.
- 专注于病理生理学,风险因素,预测模型和对AAV心血管并发症的管理策略.
主要方法:
- 对AAV和心血管疾病现有研究的文献综述.
- 分析病理生理学,临床表现,危险因素和治疗结果.
主要成果:
- 在AAV中,心血管表现包括心肌梗塞,中风,心肌炎和主动脉炎.
- 病理生理学涉及内皮功能障碍,血管炎症和直接心脏透,由传统和非传统的危险因素加剧.
- 管理需要降低心血管风险,同时控制疾病,以最大限度地减少心脏影响.
结论:
- 尽管取得了进展,但在AAV中持续的心血管疾病和死亡率需要改进的预测工具和个性化策略.
- 需要进一步的研究,以加强对AAV患者心血管并发症的预防和管理.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K